After months of market tumult caused public biotechnology valuations to plummet, shares hit all-time highs in late May. The SPDR S&P Biotech ETF is up ...
News
- Pharma dealmakers, sidelined in pandemic, are ready for comeback
- Study suggests Baboon model could aide in Alzheimer's disease interventions
San Antonio, Texas (June 8, 2020) - Scientists at Texas Biomedical Research Institute's (Texas Biomed) Southwest National Primate Research Center ...
- bioAffinity Technologies Validation Trial for Non-Invasive Lung Cancer Test Results in High ...
SAN ANTONIO--(BUSINESS WIRE)--Jun 10, 2020--. bioAffinity Technologies, a privately held biotech company, today announced its test validation ...
- What a Cancelled Gathering in Chicago Says About San Antonio's Future as a 'Convention City'
It's been much the same with the meetings of the ophthalmologists, the orthopedic surgeons, the dentists, and even the annual biotechnology event BIO ...
- Enzo Biochem: Fiscal 3Q Earnings Snapshot
On an adjusted basis, the 2019 fiscal third-quarter loss totaled $6.1 million, or 13 cents per share. The life sciences and biotechnology company posted ...